• ISSN 1674-8301
  • CN 32-1810/R
Volume 26 Issue 3
May  2012
Turn off MathJax
Article Contents

Ashish Kumar Sharma, Akash Sharma, Rita Kumari, Kunal Kishore, Divya Sharma, Bharthu Parthsarthi Srinivasan, Ashok Sharma, Santosh Kumar Singh, Samir Gaur, Vijay Singh Jatav, Prashant Sharma, Varnika Srivastava, Sneha Joshi, Megha Joshi, Prashant Kumar Dhakad, Davender Singh Kanawat, Akanksha Mishra, Anil Sharma, Dharmendra Singh, Ravinder Pal Singh, Himmat Singh Chawda, Rambir Singh, Sachin Kumar Raikwar, Muneem Kumar Kurmi, Pankaj Khatri, Ashutosh Agarwal, Arshee Munajjam. Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats[J]. The Journal of Biomedical Research, 2012, 26(3): 200-210. doi: 10.7555/JBR.26.20110054
Citation: Ashish Kumar Sharma, Akash Sharma, Rita Kumari, Kunal Kishore, Divya Sharma, Bharthu Parthsarthi Srinivasan, Ashok Sharma, Santosh Kumar Singh, Samir Gaur, Vijay Singh Jatav, Prashant Sharma, Varnika Srivastava, Sneha Joshi, Megha Joshi, Prashant Kumar Dhakad, Davender Singh Kanawat, Akanksha Mishra, Anil Sharma, Dharmendra Singh, Ravinder Pal Singh, Himmat Singh Chawda, Rambir Singh, Sachin Kumar Raikwar, Muneem Kumar Kurmi, Pankaj Khatri, Ashutosh Agarwal, Arshee Munajjam. Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats[J]. The Journal of Biomedical Research, 2012, 26(3): 200-210. doi: 10.7555/JBR.26.20110054

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats

doi: 10.7555/JBR.26.20110054
  • Received Date: 2011-05-09
  • Publish Date: 2012-06-05
  • Diabetic neuropathies are a family of nerve disorders caused by diabetes. Symptoms of the disease include nerve palsy, mononeuropathy, mononeuropathy multiplex, diabetic amyotrophy, painful polyneuropathy, autonomic neuropathy, and thoracoabdominal neuropathy. In this study, type 2 diabetes in rats was induced with nicotinamide-streptozotocin. Drug treatment was initiated on the d 15, with the combination regimen of metformin, pioglitazone and glimipiride or metformin and sitagliptin or sitagliptin, amitriptyline and sitagliptin and led to significantly improved glycemic control, increased grip strength and paw jumping response on d 21, 28 and 35 (P < 0.001). Significant increases in blood protein levels and decreases in urinary protein levels were observed in the animals treated with the different regimens on d 21, 28 and 35 (P < 0.001). Combined treatment of streptozotocin and nicotinamide caused marked degeneration of nerve cells, while administration of metformin and sitagliptin showed tissue regeneration and no body weight gain. In conclusion, treatment with sitagliptin and sitagliptin combined with metformin or amitriptyline results in no body weight gain, but causes an increase in grip strength and pain sensitivity, exhibits neural protection, and reverses the alteration of biochemical parameters in rats with streptozotocin-nicotinamide induced type 2 diabetes.
  • 加载中
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(5135) PDF downloads(56) Cited by()

Related
Proportional views

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats

doi: 10.7555/JBR.26.20110054

Abstract: Diabetic neuropathies are a family of nerve disorders caused by diabetes. Symptoms of the disease include nerve palsy, mononeuropathy, mononeuropathy multiplex, diabetic amyotrophy, painful polyneuropathy, autonomic neuropathy, and thoracoabdominal neuropathy. In this study, type 2 diabetes in rats was induced with nicotinamide-streptozotocin. Drug treatment was initiated on the d 15, with the combination regimen of metformin, pioglitazone and glimipiride or metformin and sitagliptin or sitagliptin, amitriptyline and sitagliptin and led to significantly improved glycemic control, increased grip strength and paw jumping response on d 21, 28 and 35 (P < 0.001). Significant increases in blood protein levels and decreases in urinary protein levels were observed in the animals treated with the different regimens on d 21, 28 and 35 (P < 0.001). Combined treatment of streptozotocin and nicotinamide caused marked degeneration of nerve cells, while administration of metformin and sitagliptin showed tissue regeneration and no body weight gain. In conclusion, treatment with sitagliptin and sitagliptin combined with metformin or amitriptyline results in no body weight gain, but causes an increase in grip strength and pain sensitivity, exhibits neural protection, and reverses the alteration of biochemical parameters in rats with streptozotocin-nicotinamide induced type 2 diabetes.

Ashish Kumar Sharma, Akash Sharma, Rita Kumari, Kunal Kishore, Divya Sharma, Bharthu Parthsarthi Srinivasan, Ashok Sharma, Santosh Kumar Singh, Samir Gaur, Vijay Singh Jatav, Prashant Sharma, Varnika Srivastava, Sneha Joshi, Megha Joshi, Prashant Kumar Dhakad, Davender Singh Kanawat, Akanksha Mishra, Anil Sharma, Dharmendra Singh, Ravinder Pal Singh, Himmat Singh Chawda, Rambir Singh, Sachin Kumar Raikwar, Muneem Kumar Kurmi, Pankaj Khatri, Ashutosh Agarwal, Arshee Munajjam. Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats[J]. The Journal of Biomedical Research, 2012, 26(3): 200-210. doi: 10.7555/JBR.26.20110054
Citation: Ashish Kumar Sharma, Akash Sharma, Rita Kumari, Kunal Kishore, Divya Sharma, Bharthu Parthsarthi Srinivasan, Ashok Sharma, Santosh Kumar Singh, Samir Gaur, Vijay Singh Jatav, Prashant Sharma, Varnika Srivastava, Sneha Joshi, Megha Joshi, Prashant Kumar Dhakad, Davender Singh Kanawat, Akanksha Mishra, Anil Sharma, Dharmendra Singh, Ravinder Pal Singh, Himmat Singh Chawda, Rambir Singh, Sachin Kumar Raikwar, Muneem Kumar Kurmi, Pankaj Khatri, Ashutosh Agarwal, Arshee Munajjam. Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats[J]. The Journal of Biomedical Research, 2012, 26(3): 200-210. doi: 10.7555/JBR.26.20110054

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return